Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Female”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01041235
What this trial is testing

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Who this might be right for
Solid TumorBreast CancerOvarian Cancer+2 more
Azaya Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT03435640
What this trial is testing

REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies

Who this might be right for
MelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more
Nektar Therapeutics 64
Testing effectiveness (Phase 2)WithdrawnNCT00615524
What this trial is testing

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone-receptor Positive Breast Cancer
GlaxoSmithKline
Early research (Phase 1)Active Not RecruitingNCT04288089
What this trial is testing

H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Who this might be right for
Receptors, EstrogenGenes, Erbb-2Breast Neoplasms
Eisai Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT06065059
What this trial is testing

Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors

Who this might be right for
Breast CancerOvarian CancerPancreas Cancer+5 more
Tango Therapeutics, Inc. 7
Not applicableUnknownNCT03847818
What this trial is testing

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Shandong University 268
Testing effectiveness (Phase 2)Study completedNCT00305825
What this trial is testing

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

Who this might be right for
Breast Cancer
University of California, San Francisco 43
Early research (Phase 1)Study completedNCT00513058
What this trial is testing

Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 33
Large-scale testing (Phase 3)Ended earlyNCT00508274
What this trial is testing

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT00003352
What this trial is testing

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 89
Large-scale testing (Phase 3)Study completedNCT00863655
What this trial is testing

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 724
Testing effectiveness (Phase 2)Study completedNCT00088413
What this trial is testing

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Who this might be right for
AdenocarcinomaColorectal CancerOvarian Cancer+1 more
National Cancer Institute (NCI) 51
Early research (Phase 1)Study completedNCT01795586
What this trial is testing

A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 19
Large-scale testing (Phase 3)Study completedNCT00002662
What this trial is testing

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Aventis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00796107
What this trial is testing

R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 6
Early research (Phase 1)Ended earlyNCT06052852
What this trial is testing

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more
Bolt Biotherapeutics, Inc. 17
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Early research (Phase 1)WithdrawnNCT02627430
What this trial is testing

Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer

Who this might be right for
Adult Solid NeoplasmEstrogen Receptor NegativeFallopian Tube Serous Neoplasm+10 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Testing effectiveness (Phase 2)Study completedNCT03781063
What this trial is testing

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
Sermonix Pharmaceuticals Inc. 100
Next Page